Cargando…

HBcAb positivity increases the risk of postoperative complications after extended hemihepatectomy for hilar cholangiocarcinoma

BACKGROUND: Hepatitis B core antibody (HBcAb) positivity is considered a prior hepatitis B virus (HBV) infection. However, little is known about the effect of HBcAb positivity on surgical safety for hilar cholangiocarcinoma (hCCA). The present study aims to investigate the role of HBcAb positivity o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Wen‐Qiang, Xu, Guang‐Yuan, Li, Jian, Liang, Bin‐Yong, Li, Jiang, Lin, Mei‐Long, Chen, Xiao‐Ping, Zhang, Er‐Lei, Huang, Zhi‐Yong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	RESEARCH ARTICLES
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10166974/ https://www.ncbi.nlm.nih.gov/pubmed/36847156 http://dx.doi.org/10.1002/cam4.5740

Ejemplares similares

HBsAb and HBcAb Have No Significant Effect on the Progression of SLE and RA
por: WANG, Fen, et al.
Publicado: (2017)

Management of the HBV reactivation in isolated HBcAb positive patients affected with Non Hodgkin Lymphoma
por: Masarone, Mario, et al.
Publicado: (2014)

Hepatitis B sero-prevalence among hematology patients: importance of Anti-HbcAb and efficiency of antiviral prophylaxis
por: Kantar, Funda Ugur, et al.
Publicado: (2022)

Moderate Risk of Hepatitis B Virus Reactivation in HBsAg(−)/HBcAb(+) Carriers Receiving Rituximab for Rheumatoid Arthritis
por: Kuo, Meng Hsuan, et al.
Publicado: (2020)

Lack of evidence of viral reactivation in HBsAg-negative HBcAb-positive and HCV patients undergoing immunosuppressive therapy for psoriasis
por: Morisco, Filomena, et al.
Publicado: (2014)

Hepatitis B Reactivation in a HBsAg-Negative, HBcAb-Positive Patient Receiving Fludarabine for the Treatment of Chronic Lymphocytic Leukaemia
por: Toscanini, Federica, et al.
Publicado: (2011)

HBcAb seropositivity is correlated with poor HIV viremia control in an Italian cohort of HIV/HBV-coinfected patients on first-line therapy
por: Malagnino, Vincenzo, et al.
Publicado: (2019)

Baseline quantitative HBcAb strongly predicts undetectable HBV DNA and RNA in chronic hepatitis B patients treated with entecavir for 10 years
por: Zhang, Xi, et al.
Publicado: (2021)

A New Surgical Procedure “Dumbbell-Form Resection” for Selected Hilar Cholangiocarcinomas With Severe Jaundice: Comparison With Hemihepatectomy
por: Wang, Shuguang, et al.
Publicado: (2016)

Prevalence of Cirrhosis/Advanced Fibrosis Among HBsAg-Negative and HBcAb-Positive US Adults: A Nationwide Population-Based Study
por: Huang, Shuai-Wen, et al.
Publicado: (2022)

Long-Term Safety in HBsAg-Negative, HBcAb-Positive Patients with Rheumatic Diseases Receiving Maintained Steroid Therapy after Pulse Therapy
por: Lin, Ying-Cheng, et al.
Publicado: (2021)

Risk of hepatitis B reactivation in HBsAg−/HBcAb+ patients after biologic or JAK inhibitor therapy for rheumatoid arthritis: A meta‐analysis
por: Hong, Xuezhi, et al.
Publicado: (2023)

HBcAb Positivity Increases the Risk of Severe Hepatic Fibrosis Development in HIV/HCV-Positive Subjects From the ICONA Italian Cohort of HIV-Infected Patients
por: Malagnino, Vincenzo, et al.
Publicado: (2020)

Extended lymphadenectomy in hilar cholangiocarcinoma: What it will bring?
por: Li, Jian, et al.
Publicado: (2020)

Poor CD4/CD8 ratio recovery in HBcAb-positive HIV patients with worse immune status is associated with significantly higher CD8 cell numbers
por: Malagnino, Vincenzo, et al.
Publicado: (2021)

Adverse Effects of Sarcopenic Obesity on Postoperative Complications after Major Hepatectomy in Patients with Hilar Cholangiocarcinoma
por: Lee, Okjoo, et al.
Publicado: (2022)

Changes in hepatitis B virus surface antibody titer and risk of hepatitis B reactivation in HBsAg-negative/HBcAb-positive patients undergoing biologic therapy for rheumatic diseases: a prospective cohort study
por: Tien, Ya-Chih, et al.
Publicado: (2018)

Augmented reality navigation in open surgery for hilar cholangiocarcinoma resection with hemihepatectomy using video-based in situ three-dimensional anatomical modeling: A case report
por: Tang, Rui, et al.
Publicado: (2017)

Resection of Hilar Cholangiocarcinoma
por: Strasberg, Steven M.
Publicado: (1998)

Comparison study for surgical outcomes of right versus left side hemihepatectomy to treat hilar cholangiocellular carcinoma
por: Hong, Seung Soo, et al.
Publicado: (2020)

Lamivudine 24-month-long prophylaxis is a safe and efficient choice for the prevention of hepatitis B virus reactivation in HBsAg-negative/HBcAb-positive patients with advanced DLBCL undergoing upfront R-CHOP-21
por: Giordano, Claudia, et al.
Publicado: (2023)

Postoperative morbidity adversely impacts oncological prognosis after curative resection for hilar cholangiocarcinoma
por: Liu, Zhi-Peng, et al.
Publicado: (2022)

Laparoscopic resection of hilar cholangiocarcinoma
por: Lee, Woohyung, et al.
Publicado: (2015)

HBcAb Positivity Is a Risk Factor for an Increased Detectability of HIV RNA after Switching to a Two-Drug Regimen Lamivudine-Based (2DR-3TC-Based) Treatment: Analysis of a Multicenter Italian Cohort
por: Malagnino, Vincenzo, et al.
Publicado: (2021)

Role of HBcAb Positivity in Increase of HIV-RNA Detectability after Switching to a Two-Drug Regimen Lamivudine-Based (2DR-3TC-Based) Treatment: Months 48 Results of a Multicenter Italian Cohort
por: Malagnino, Vincenzo, et al.
Publicado: (2023)

Relationship of tumor size with pathological and prognostic factors for hilar cholangiocarcinoma
por: Hu, Hai-Jie, et al.
Publicado: (2017)

Preoperative ICG Test to Predict Posthepatectomy Liver Failure and Postoperative Outcomes in Hilar Cholangiocarcinoma
por: Li, Min, et al.
Publicado: (2021)

Insertion of I-125 seed-loaded stent for inoperable hilar cholangiocarcinoma
por: Gao, Fu-Lei, et al.
Publicado: (2021)

Surgical treatment of hilar cholangiocarcinoma: retrospective analysis
por: Li, Bin, et al.
Publicado: (2023)

Duodenoportal fistula caused by peptic ulcer after extended right hepatectomy for hilar cholangiocarcinoma
por: Kinoshita, Hiroyuki, et al.
Publicado: (2006)

The Role of Photodynamic Therapy for Hilar Cholangiocarcinoma
por: Cheon, Young Koog
Publicado: (2010)

PROTOCOL FOR LIVER TRANSPLANTATION IN HILAR CHOLANGIOCARCINOMA
por: ERNANI, Lucas, et al.
Publicado: (2021)

Non-surgical treatment of hilar cholangiocarcinoma
por: Inchingolo, Riccardo, et al.
Publicado: (2021)

FXR expression in rats of hilar cholangiocarcinoma
por: Zhang, Meng-yu, et al.
Publicado: (2022)

Prognostic significance of snail expression in hilar cholangiocarcinoma
por: Kong, Dalu, et al.
Publicado: (2012)

Mesohepatectomy Versus Extended Hemihepatectomies for Centrally Located Liver Tumors: A Meta-Analysis
por: Li, Jianbo, et al.
Publicado: (2017)

Perineural invasion of hilar cholangiocarcinoma in Chinese population: One center’s experience
por: Li, Cheng-Gang, et al.
Publicado: (2020)

The prognostic potential and oncogenic effects of PRR11 expression in hilar cholangiocarcinoma
por: Chen, Ying, et al.
Publicado: (2015)

Safety and feasibility of laparoscopy technology in right hemihepatectomy
por: Yu, Xin, et al.
Publicado: (2019)

Changing Perspectives in the Assessment of Resectability of Hilar Cholangiocarcinoma
por: van Gulik, Thomas M., et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_5h78ifo070cogo8l98tg8i9q6q